Literature DB >> 18989696

Reflux esophagitis, high-grade neoplasia, and early Barrett's carcinoma-what is the place of the Merendino procedure?

A H Hölscher1, D Vallböhmer, C Gutschow, E Bollschweiler.   

Abstract

INTRODUCTION: Because of the increasing frequency of Barrett's cancer in Western industrialized countries, the management of reflux disease with the potential development of Barrett's esophagus, neoplasia, and early carcinoma is very important. In case of established Barrett's esophagus, the malignant degeneration of the specialized epithelium cannot definitely be prevented by antireflux surgery or continuous medication. Mucosal adenocarcinomas nearly never develop lymph node metastasis and can mostly be treated by endoscopic mucosectomy. The deeper the submucosa is infiltrated, the higher is the rate of lymph node metastasis which is, on the average, 30% for submucosal carcinoma.
CONCLUSIONS: Therefore, radical subtotal esophagectomy is the treatment of choice for submucosal carcinoma, whereas distal esophageal resection with limited lymph node dissection is only indicated in mucosal carcinoma which cannot be completely removed by interventional endoscopy.

Entities:  

Mesh:

Year:  2008        PMID: 18989696     DOI: 10.1007/s00423-008-0429-9

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  58 in total

1.  Superficial oesophageal carcinoma: is there a need for three-field lymphadenectomy?

Authors:  T W Rice
Journal:  Lancet       Date:  1999-09-04       Impact factor: 79.321

2.  Prognostic influence of Barrett's oesophagus and Helicobacter pylori infection on healing of erosive gastro-oesophageal reflux disease (GORD) and symptom resolution in non-erosive GORD: report from the ProGORD study.

Authors:  P Malfertheiner; T Lind; S Willich; M Vieth; D Jaspersen; J Labenz; W Meyer-Sabellek; O Junghard; M Stolte
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

3.  Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1,128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms.

Authors:  M Voutilainen; P Sipponen; J P Mecklin; M Juhola; M Färkkilä
Journal:  Digestion       Date:  2000       Impact factor: 3.216

4.  Limited resection for early adenocarcinoma in Barrett's esophagus.

Authors:  H J Stein; M Feith; J Mueller; M Werner; J R Siewert
Journal:  Ann Surg       Date:  2000-12       Impact factor: 12.969

5.  Survivin, a potential biomarker in the development of Barrett's adenocarcinoma.

Authors:  Daniel Vallböhmer; Jeffrey H Peters; Daniel Oh; Hidekazu Kuramochi; Daisuke Shimizu; Steven R Demeester; Jeffrey A Hagen; Parakrama T Chandrasoma; Kathleen D Danenberg; Tom R DeMeester; Peter Danenberg
Journal:  Surgery       Date:  2005-10       Impact factor: 3.982

6.  Natural history of early gastric cancer: a non-concurrent, long term, follow up study.

Authors:  H Tsukuma; A Oshima; H Narahara; T Morii
Journal:  Gut       Date:  2000-11       Impact factor: 23.059

7.  Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux.

Authors:  M Solaymani-Dodaran; R F A Logan; J West; T Card; C Coupland
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

8.  Gastrointestinal epithelial neoplasia: Vienna revisited.

Authors:  M F Dixon
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

Review 9.  The effect of antireflux surgery on esophageal carcinogenesis in patients with barrett esophagus: a systematic review.

Authors:  Eugene Y Chang; Cynthia D Morris; Ann K Seltman; Robert W O'Rourke; Benjamin K Chan; John G Hunter; Blair A Jobe
Journal:  Ann Surg       Date:  2007-07       Impact factor: 12.969

10.  The European experience with esophageal cancer limited to the mucosa and submucosa.

Authors:  P Froelicher; G Miller
Journal:  Gastrointest Endosc       Date:  1986-04       Impact factor: 9.427

View more
  8 in total

1.  [A rare vascular variation with great importance in esophageal surgery].

Authors:  E Theodoridou; H R Mahlo; M Pauthner; T Haist
Journal:  Chirurg       Date:  2019-01       Impact factor: 0.955

2.  Prognosis of patients with superficial T1 esophageal cancer who underwent endoscopic resection before esophagectomy-A propensity score-matched comparison.

Authors:  Patrick Sven Plum; Arnulf Heinrich Hölscher; Kristin Pacheco Godoy; Henner Schmidt; Felix Berlth; Seung-Hun Chon; Hakan Alakus; Elfriede Bollschweiler
Journal:  Surg Endosc       Date:  2018-03-13       Impact factor: 4.584

3.  How radical should surgery be for early esophageal cancer?

Authors:  Dean Bogoevski; Maximilian Bockhorn; Alexandra Koenig; Matthias Reeh; Katharina von Loga; Guido Sauter; Thomas Rösch; Jakob R Izbicki
Journal:  World J Surg       Date:  2011-06       Impact factor: 3.352

Review 4.  [Surgical strategy for early stage carcinoma of the esophagus].

Authors:  N Niclauss; M Chevallay; J L Frossard; S P Mönig
Journal:  Chirurg       Date:  2018-05       Impact factor: 0.955

5.  Esophagogastric tube reconstruction with stapled pseudo-fornix in laparoscopic proximal gastrectomy: a novel technique proposed for Siewert type II tumors.

Authors:  Hisahiro Hosogi; Fumihiro Yoshimura; Tadayoshi Yamaura; Seiji Satoh; Ichiro Uyama; Seiichiro Kanaya
Journal:  Langenbecks Arch Surg       Date:  2014-01-15       Impact factor: 3.445

Review 6.  Management strategies of Barrett's esophagus.

Authors:  Giovanni D De Palma
Journal:  World J Gastroenterol       Date:  2012-11-21       Impact factor: 5.742

7.  Quality of life after surgical treatment of early Barrett's cancer: a prospective comparison of the Ivor-Lewis resection versus the modified Merendino resection.

Authors:  Ch Zapletal; Ch Heesen; J Origer; M Pauthner; O Pech; Ch Ell; Dietmar Lorenz
Journal:  World J Surg       Date:  2014-06       Impact factor: 3.352

8.  Esophageal leiomyomatosis combined with intrathoracic stomach and gastric volvulus.

Authors:  Firas W Obeidat; Reinhold A Lang; Florian Löhe; Christian Graeb; Carsten Rist; Karl-Walter Jauch; Tanija K Hüttl; Thomas P Hüttl
Journal:  JSLS       Date:  2009 Jul-Sep       Impact factor: 2.172

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.